New cryptosporidiosis treatment. FDA panel rejects drug for cryptosporidial diarrhea. FDA rejects nitazoxanide, approves TB and hepatitis treatments. Diarrhea drug rejection raises a ruckus. Advisory Committee votes against approval.
Opportunistic infections update.
See p. 18. Nitazoxanide for cryptosporidial diarrhea. See p. 18-19. NTZ submitted to FDA for cryptosporidiosis. Fruhlingstraum, or, what it takes to mend an immune system.